CMS has taken a step in its ongoing efforts to manage healthcare costs by extending the negotiation timeline for Medicare drug price cuts. This decision, announced on Wednesday, is part of a broader ...

Starting in 2025, Medicare ... drugs has been released, showing dramatic potential savings. For example, one medication currently costing $13,836 for a 30-day supply could see significant price ...

In a strategic move to refine the Medicare drug pricing negotiations, the U.S. government announced an extension of the ...

The U.S. government will provide more time for negotiations and more chances for drugmakers to submit counter offers during ...

Now that the U.S. government has negotiated prices for some Medicare ... price. Medicare spent over $4.6 billion on the drug in 2022. Bristol Myers' Pomalyst and two other Abbvie drugs, Vraylar ...

American Hospital Association CEO Rick Pollack says a new hostility on Capitol Hill stems from competitors and populism — and ...

Ahead of the election, the Orange County Register compiled a list of questions from our readers to pose to the candidates who ...

More about Jim Tankersley Medicare Drug Premiums: Federal regulators spent billions of dollars so that older Americans would face lower average monthly premiums for their prescription drugs.

But there are other likely reasons besides the bribery scandal for the slowdown, Anderson writes, such as price cuts in ... to 2004 and then headed the Centers for Medicaid & Medicare Services ...

Medicare is set to negotiate the prices of 15 more drugs. Medicines that will probably be on the list are used for conditions ...

Now that the first round of price negotiations is complete, CMS' new guidelines will provide more time for drugmakers to make ...